Disseminated salmonellosis in a patient treated with temozolomide

被引：7

作者：

Georgescu, Georgiana ^{[1
]}

Isola, Ignatio M. ^{[2
]}

Youssef, Souad ^{[3
]}

Adachi, Javier

Rolston, Kenneth

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA

[2] Ctr Educ Med & Invest Clin, Dept Internal Med, Buenos Aires, DF, Argentina

[3] Mem Hlth Syst E Texas, Livingston, TX 77351 USA

来源：

JOURNAL OF INFECTION | 2008年 / 57卷 / 05期

关键词：

Temozolomide; CD4(+); T-tymphocytopenia; Salmonella;

D O I：

10.1016/j.jinf.2008.06.021

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Temozolomide is a relatively new chemotherapeutic agent frequently associated with selective CD4(+) T-tymphocytopenia. Patients with cell-mediated immune defects are at higher risk for acquiring infections with Salmonella species. We describe the first case of disseminated salmonellosis in a patient treated with temozolomide. (c) 2008 The British Infection Society. Published by Elsevier Ltd. All rights reserved.

引用

页码：414 / 415

页数：2

共 7 条

[1] Temozolomide for melanoma: new toxicities and new opportunities [J].

Gajewski, TF .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) :580-581

[2] Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide [J].

Ganiere, Vincent ;

Christen, Gregoire ;

Bally, Frank ;

Guillou, Louis ;

Pica, Alessia ;

de Ribaupierre, Sandrine ;

Stupp, Roger .

NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (06) :339-343

[3] Salmonella infections in immunocompromised adults [J].

Gordon, Melita A. .

JOURNAL OF INFECTION, 2008, 56 (06) :413-422

[4]

Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457

[5] Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors [J].

Kulke, MH ;

Stuart, K ;

Enzinger, PC ;

Ryan, DP ;

Clark, JW ;

Muzikansky, A ;

Vincitore, M ;

Michelini, A ;

Fuchs, CS .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) :401-406

[6]

*NCCN, 2007, NCCN CLIN PRACT GUID

[7] Selective CD4+ lymphopenia in melanoma patients treated with temozolomide:: A toxicity with therapeutic implications [J].

Su, YB ;

Sohn, S ;

Krown, SE ;

Livingston, PO ;

Wolchok, JD ;

Quinn, C ;

Williams, L ;

Foster, T ;

Sepkowitz, KA ;

Chapman, PB .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) :610-616

← 1 →